Citations

Showing 10 of 108104 citations.

Brain-Derived Neurotrophic Factor and Its Associations with Metabolism and Physical Activity in a Latino Sample
Fonseca, Rodrigo , Shaibi, Gabriel Q. , Caselli, Richard J. , Mandarino, Lawrence J. , Hentz, Joseph G. , Filippis, Elena A. De, Dawit, Sara, Geda, Yonas E. , Krell-Roesch, Janina, De Filippis, Elena Anna, Geda, Yonas E , Fonseca, Rodrigo , Krell‐Roesch, Janina , Zhang, Nan , Coletta, Dawn K.

Mayo Clinic

Metabolic Syndrome and Related Disorders | November 12, 2018 | Volume: 17 | Issue: 2 | Pages: 75-80

10.1089/met.2018.0028 | PMID 30418087 Get It

Background: Brain-derived neurotrophic factor (BDNF) is associated with body weight and other health conditions but remains understudied in the Latino population. The aim of this study was to examine the associations of BDNF serum levels with body mass index (BMI), physical activity, and the rs6265 nonconservative polymorphism among 349 Latinos aged ≥18 years enrolled in the Arizona Insulin Resistance Registry. Materials and Methods: Data on physical activity were acquired using a self-reported questionnaire. BDNF serum levels were measured utilizing a modified ELISA method, and the rs6265 polymorphism was genotyped by the Assay-by-Design service. Two sample t -tests or chi-squared tests were employed to compare demographics and outcomes between physically active and nonactive groups as well as between rs6265 CC and CT+TT groups. Results: BDNF levels and rs6265 polymorphism did not differ significantly between the physically active ( N = 195) and nonactive group ( N = 154). Participants with the rs6265 polymorphism did not show any significant difference in BDNF levels or BMI when compared with those with the normal functional variant. Higher BDNF levels were significantly associated with higher age ( r = 0.11, P = 0.04) and higher 2-hr glucose level ( r = 0.11, P = 0.04). Conclusions: In this cross-sectional study, the rs6265 polymorphism was not associated with a higher risk of obesity, or lower circulating levels of BDNF. Thus, the rs6265 polymorphism may have a different impact in Latinos as compared with other previously studied populations.
miR‑205 targets runt‑related transcription factor�2 to inhibit human pancreatic cancer progression
Zhuang, Lu, Guo, Jia , Li, Zhao‐Shen , Yao, Yao

Mayo Clinic

Oncology Letters | November 12, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3892/ol.2018.9689 | PMID 30655837 Get It

Cytology of the fallopian tube: A screening model for high-grade serous carcinoma
Dhanani, Maya, Charles, Mélissa S., Dinh, Tri, Nassar, Aziza

Mayo Clinic

CytoJournal | November 12, 2018 | Volume: 15 | Issue: No issue available | Pages: 28

10.4103/cytojournal.cytojournal_58_17 | PMID 30534183 Get It

Ovarian cancer is a heterogeneous disease having the highest gynecologic fatality in the United States with a 5-year survival rate of 46.5%. Poor overall prognosis is mostly attributed to inadequate screening tools, and the majority of diagnoses occur at late stages of the disease. Due to genetic and biological underpinnings, ovarian high-grade serous carcinomas (HGSC) have etiologic evidence in the distal fallopian tube. Fallopian tube screening modalities are aggressively investigated, but few describe cytological characteristics of benign tubal specimens to help in the comparative detection of HGSC precursor cells. Here, we describe fimbrial cytomorphological and nuclear features of tubal specimens (n = 75) from patients clinically indicated for salpingectomy, bilateral or unilateral salpingo-oophorectomy, and hysterectomies for any diagnosis other than ovarian or peritoneal cancer. Fallopian tube histology was used as the diagnostic reference. A total of 75 samples had benign diagnoses. The benign cytological characteristics of fimbrial tubal specimens included ciliated cells in clustered arrangements with mild nuclear membrane irregularity, mild anisonucleosis, round and/or oval nuclei, hyperchromatic chromatin, and mild nuclear membrane irregularity. In contrast, none of the cytology samples had spindle-shaped nuclei, significantly marked anisonucleosis (n = 1), nor had hypochromasia as a characteristic feature. These cytological characteristics could be a potential area of distinction from HGSC precursor cells. Our study establishes cytomorphological characteristics of nonmalignant tubal cells which help underscore the importance of distinguishing malignant HGSC precursors through fimbrial brush sampling in minimally invasive approach.
Author response: Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
Liao, Lili, Langbein, Lauren , Cho, Eun-Ah , Niu, Xiaohua , Jiang, Wei , Zhong, Zhijiu , Jagannathan, Geetha , Dulaimi, Essel, Testa, Joseph R. , Wang, Yuxin , Stark, George R. , Peiper, Stephen, Yang, Haifeng , Liu, Zongzhi Z. , Cai, Weijia , Na, Jie, Cai, Wesley L. , Uzzo, Robert G. , Sun, Jianxin , Xu, Yaomin , Yan, Qin

Mayo Clinic

No container title available | November 12, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.37925.029 Get It

Regenerative Prophylaxis In Utero
Ruano, Rodrigo , Enninga, Elizabeth Ann L. , Rivera, Paola E. Brana, Brana Rivera, Paola E, Ruano, Rodrigo , Enninga, Elizabeth Ann L , Terzic, André

Mayo Clinic

Clinical Pharmacology & Therapeutics | November 12, 2018 | Volume: 105 | Issue: 1 | Pages: 39-41

10.1002/cpt.1262 | PMID 30417507 Get It

Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia
Gilbert, Travis T., Arfstrom, Rachel J., Mihalovic, Scott W., Dababneh, Ala S. , Palraj, Bharath Raj, Dierkhising, Ross , Mara, Kristin C. , Lessard, Sarah , Palraj, Raj , Dierkhising, Ross A, Lessard, Sarah R, Mara, Kristin C , Palraj, Raj

Mayo Clinic

American Journal of Therapeutics | November 12, 2018 | Volume: 27 | Issue: 2 | Pages: e177-e182

10.1097/mjt.0000000000000788 | PMID 30418221 Get It

Background: Antibiotic therapy with a macrolide and β-lactam or a fluoroquinolone for the empirical treatment of community-acquired pneumonia (CAP) in an inpatient non–intensive care setting is recommended per guidelines. Studies show that these treatments have similar outcomes, including death, adverse effects, and bacterial eradication. However, a comparison of 30-day readmission rates between these treatments is limited. Study Question: To determine whether 30-day readmissions for patients treated for CAP in a regional hospital differed between a fluoroquinolone monotherapy and a β-lactam plus macrolide combination therapy. Study Design: Retrospective cohort study of patients aged ≥18 years with a CAP diagnosis who were admitted to the same regional hospital from December 1, 2011, through December 1, 2016. Measures and Outcomes: Patients receiving a third-generation cephalosporin plus macrolide were compared with those receiving a respiratory fluoroquinolone. Exclusion criteria were concurrent or recent use of the study antibiotics; death, transfer, or transition to hospice; and diagnosis of hospital-acquired pneumonia or health care–associated pneumonia. The collected data were 30-day readmission rates, antibiotic regimens, demographic characteristics, and pneumonia severity index and comorbidity scores. Association between treatment group and readmissions was assessed with logistic regression. Association between readmissions and individual data points between the 2 treatment groups was calculated with multivariate regression and odds ratio (95% confidence interval). Results: Of 432 patients, 171 met inclusion criteria (fluoroquinolone group, n = 101; β-lactam plus macrolide group, n = 70). Thirty-day readmissions were not significantly different between the fluoroquinolone group and β-lactam plus macrolide group (P = 0.58). Increased 30-day readmissions were independently associated with male sex and hospital length of stay (P < 0.05). Length of stay was approximately 3 days and did not differ between treatment groups. Conclusions: No difference was seen in 30-day readmissions between CAP patients who received fluoroquinolone monotherapy and those who received β-lactam plus macrolide combination therapy.
Retinal signs and risk of incident dementia in the Atherosclerosis Risk in Communities study
Sharrett, A. Richey, Albert, Marilyn , Bandeen‐Roche, Karen , Burgard, Sheila , Thomas, Sonia , Klein, Barbara E.K. , Deal, Jennifer A. , Gottesman, Rebecca F. , Knopman, David S. , Mosley, Thomas H. , Klein, Ronald , Thomas, Sonia M

Mayo Clinic

Alzheimer's & Dementia | November 11, 2018 | Volume: 15 | Issue: 3 | Pages: 477-486

10.1016/j.jalz.2018.10.002 | PMID 30439332 Get It

AbstractIntroductionThe easily‐imaged retinal microvasculature may reflect the brain microvasculature and therefore be related to dementia.MethodsIn a population‐based study of 12,482 adults aged 50‐73 years (22% African American), we estimated the relationship of retinal characteristics from fundus photography (1993‐1995) with incident all‐cause dementia (1993‐1995 to 2011‐2013) and with etiologic subtype of dementia/mild cognitive impairment (2011‐13).ResultsA total of 1259 (10%) participants developed dementia over a mean 15.6 years. Moderate/severe (vs. no) retinopathy (hazard ratio [HR], 1.86; 95% confidence interval [CI]: 1.36–2.55) and central retinal arteriolar equivalent (narrowest quartile vs. widest three quartiles; HR, 1.26; 95% CI: 1.09–1.45) were associated with all‐cause dementia. Results were qualitatively stronger (but not statistically significantly different) in participants with diabetes. Retinopathy was associated with a joint outcome of cerebrovascular‐related, but not Alzheimer's disease–related, dementia/mild cognitive impairment (HR, 2.29; 95% CI: 1.24–4.23).DiscussionExploration of measures in the eye may provide surrogate indices of microvascular lesions relevant to dementia.
CENTRALIZED COGNITIVE ASSESSMENT IN A MULTICENTER TRIAL OF TREATMENT MODES FOR ASYMPTOMATIC CAROTID ARTERY DISEASE
Wadley, Virginia G. , Lal, Brajesh K. , Brott, Thomas G. , Lazar, Ronald M. , Howard, Virginia J. , Knopman, David S. , Meschia, James F. , Howard, George

Mayo Clinic

Innovation in Aging | November 10, 2018 | Volume: 2 | Issue: suppl_1 | Pages: 702-702

10.1093/geroni/igy023.2607 Get It

RELATIONSHIPS OF MID-LIFE INFARCT BURDEN WITH LATE-LIFE MILD COGNITIVE IMPAIRMENT AND DEMENTIA: THE ARIC STUDY
Windham, B. Gwen , Griswold, Michael , Wang, W, Knopman, David S. , Gottesman, Rebecca F. , Shibata, Dean , Mosley, Thomas H.

Mayo Clinic

Innovation in Aging | November 10, 2018 | Volume: 2 | Issue: suppl_1 | Pages: 771-771

10.1093/geroni/igy023.2854 Get It